Hosted on MSN11d
‘Here’s How I Knew I Had Lung Cancer’: One Patient’s Story with Relatively Low Risk Factor
Predominantly diagnosed in those aged 65 and older, lung cancer is the leading cause of cancer death in the country ... one ...
Lung cancer is leading cause of cancer death with low early diagnosis rate
The American Lung Association said lung cancer is the leading cause of cancer deaths in the Sunshine State as well as the United States. And that the rate of early diagnosis in Florida is far too low ...
Medscape12d
Lung CT Can Detect Coronary Artery Disease, Predict Death
Lung cancer screening with low-dose CT can detect extensive coronary artery calcium, an independent predictor of all-cause ...
Onlymyhealth2d
Tabla Legend Zakir Hussain Passes Away At 73, Know How Idiopathic Pulmonary Fibrosis Can Be Fatal
Indian tabla maestro Zakir Hussain 73 passes away due to complications from idiopathic pulmonary fibrosis IPF Learn how this ...
Lung cancer screening can save lives
“Early detection can reduce lung cancer death rates by 20% — that’s significant,” Dr. Gorbatov says. “In some cases when we ...
We studied 20 places around the world and found the most common diseases linked with voluntary assisted dying
More and more countries are legalising voluntary assisted dying. But who is accessing it? The results of a recent ...
Russia’s cancer vaccine is ready. Here’s why it matters
Russia has reportedly developed a vaccine against cancer that it will launch early next year. The jab, which will be free of cost, will treat patients instead of preventing the disease in the general ...
Onlymyhealth5d
Precision Medicine: Tailored Cancer Treatments For Better Survival And Quality of Life
Precision medicine is an innovative approach that tailors treatment to the unique genetic and molecular characteristics of a ...
pulmonologyadvisor7d
Imfinzi Approved for Limited-Stage Small Cell Lung Cancer
The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), as a single agent, for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has ...
After Lung Cancer Approval, AstraZeneca's Imfinzi Goes Under FDA Priority Review For Bladder Cancer
AstraZeneca's Imfinzi gains FDA Priority Review for bladder cancer. Key trial data shows improved survival and progression ...
Joplin Globe13d
IMFINZI® (durvalumab) approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer
AstraZeneca’s IMFINZI ® (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following ...